Aharon Schwartz
Director · Protalix BioTherapeutics, Inc.
IndividualBuying only
- 2025
- Sep 9, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Aharon Schwartz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Amos Bar-Shalev - $314 in PLX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Aharon Schwartz?
Aharon Schwartz is a corporate insider, tracked as Director of Protalix BioTherapeutics, Inc. (PLX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Aharon Schwartz submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Aharon Schwartz been buying or selling stock?
Recorded transactions: 1 open-market purchase ($206K) and 0 open-market sales across all tracked filings.
